This funding opportunity supports quality improvement initiatives aimed at advancing multidisciplinary care for hemophilia. Projects should focus on enhancing care coordination and treatment outcomes for hemophilia patients within China. The grant encourages innovative approaches to improve the quality of hemophilia care through collaborative, multidisciplinary efforts.
Applicants must be based in China. Eligibility is geographically restricted to entities or individuals located within China.
